Cargando…
Use of imaging biomarkers to assess perfusion and glucose metabolism in the skeletal muscle of dystrophic mice
BACKGROUND: Duchenne muscular dystrophy (DMD) is a severe neuromuscular disease that affects 1 in 3500 boys. The disease is characterized by progressive muscle degeneration that results from mutations in or loss of the cytoskeletal protein, dystrophin, from the glycoprotein membrane complex, thus in...
Autores principales: | Ahmad, Nabeel, Welch, Ian, Grange, Robert, Hadway, Jennifer, Dhanvantari, Savita, Hill, David, Lee, Ting-Yim, Hoffman, Lisa M |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3141608/ https://www.ncbi.nlm.nih.gov/pubmed/21639930 http://dx.doi.org/10.1186/1471-2474-12-127 |
Ejemplares similares
-
ANG1 treatment reduces muscle pathology and prevents a decline in perfusion in DMD mice
por: Gutpell, Kelly M., et al.
Publicado: (2017) -
Hormonal Receptors in Skeletal Muscles of Dystrophic Mdx Mice
por: Feder, David, et al.
Publicado: (2013) -
Irisin treatment improves healing of dystrophic skeletal muscle
por: Reza, Musarrat Maisha, et al.
Publicado: (2017) -
Impaired Adaptive Response to Mechanical Overloading in Dystrophic Skeletal Muscle
por: Joanne, Pierre, et al.
Publicado: (2012) -
Alterations of cAMP-dependent signaling in dystrophic skeletal muscle
por: Rudolf, Rüdiger, et al.
Publicado: (2013)